Следене
Vittal Shivva
Vittal Shivva
Senior Scientist at Genentech
Потвърден имейл адрес: gene.com
Заглавие
Позовавания
Позовавания
Година
Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high‐performance liquid chromatography and its application to a pharmacokinetic study
S Vittal, NR Shitut, TR Kumar, MCA Vinu, R Mullangi, NR Srinivas
Biomedical Chromatography 20 (11), 1252-1259, 2006
682006
The Population Pharmacokinetics of d-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
V Shivva, PJ Cox, K Clarke, RL Veech, IG Tucker, SB Duffull
The AAPS journal 18, 678-688, 2016
642016
An approach for identifiability of population pharmacokinetic–pharmacodynamic models
V Shivva, J Korell, IG Tucker, SB Duffull
CPT: pharmacometrics & systems pharmacology 2 (6), 1-9, 2013
482013
Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: application to a clinical …
S Vittal, R Ganneboina, B Layek, RK Trivedi, KK Hotha, DV Bharathi, ...
Biomedical Chromatography 23 (4), 390-396, 2009
232009
An In Silico Knockout Model for Gastrointestinal Absorption Using a Systems Pharmacology Approach - Development and Application for Ketones
V Shivva, IG Tucker, SB Duffull
PLoS ONE 11 (9), 1-17, 2016
92016
Parameterisation affects identifiability of population models
V Shivva, J Korell, IG Tucker, SB Duffull
Journal of pharmacokinetics and pharmacodynamics 41, 81-86, 2014
82014
Chiral bioanalysis of torcetrapib enantiomers in hamster plasma by normal-phase liquid chromatography and detection by atmospheric pressure chemical ionization tandem mass …
RK Trivedi, B Layek, TS Kumar, S Vittal, R Ganneboina, PK Dubey, ...
Journal of Chromatography B 860 (2), 227-234, 2007
82007
Novel anti-LY6G6D/CD3 T-cell–dependent bispecific antibody for the treatment of colorectal cancer
P Wang, LL Sun, R Clark, M Hristopoulos, CPC Chiu, M Dillon, WY Lin, ...
Molecular Cancer Therapeutics 21 (6), 974-985, 2022
62022
Species difference in the in vitro and in vivo metabolism of amtolmetin guacil
KK Hotha, VB Dasari, AN Shaik, M Syed, V Shivva, RK Lakshmanarao, ...
Arzneimittelforschung 60 (11), 667-674, 2010
62010
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema
NJ Agard, G Zhang, J Ridgeway, DM Dicara, PY Chu, R Ohri, S Sanowar, ...
Translational Vision Science & Technology 11 (10), 27-27, 2022
52022
Antibody format and serum disposition govern ocular pharmacokinetics of intravenously administered protein therapeutics
V Shivva, CA Boswell, H Rafidi, RF Kelley, AV Kamath, SR Crowell
Frontiers in Pharmacology 12, 601569, 2021
52021
Safety, tolerability, pharmacokinetic and pharmacodynamic profile of multiple-doses of DRL-17822, a potent cholesteryl ester transfer protein inhibitor in healthy male subjects
MR Dasari, A Bapat, S Vittal, M Tippana, S Hasham, S Alikunju, ...
Circulation 122 (suppl_21), A13981-A13981, 2010
42010
Complex PK-PD of an engineered IL-15/IL-15Rα–Fc fusion protein in cynomolgus monkeys: QSP modeling of lymphocyte dynamics
D Lu, R Yadav, P Holder, E Chiang, S Sanjabi, V Poon, M Bernett, ...
European Journal of Pharmaceutical Sciences 186, 106450, 2023
32023
Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy
S Kasichayanula, S Mandlekar, V Shivva, M Patel, S Girish
Clinical and Translational Science 15 (8), 1818-1837, 2022
32022
Il15/il15r alpha heterodimeric fc-fusion proteins for the treatment of cancer
AJP Ungewickell, V Shivva, R Yadav
US Patent App. 17/814,456, 2023
12023
In vivo reoxidation kinetics of free thiols in multiple domains of IgG1 antibodies in rats
MT Kim, M Lechmann, S Rajan, V Shivva, A Lee, Y Chen, DD Weis
Journal of Pharmaceutical Sciences 110 (5), 1989-1996, 2021
12021
Improving priors for human monoclonal antibody linear pharmacokinetic parameters by using half-lives from non-human primates
V Shivva, M Fink, PJ Lowe
Journal of Pharmacokinetics and Pharmacodynamics 48, 295-303, 2021
12021
Improving priors for human mAb linear PK parameters by using half-lives from pre-clinical species
V Shivva, PJ Lowe, M Fink
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S82-S82, 2016
12016
Safety and tolerability of single ascending doses of DRL-17822, a potent CETP inhibitor, in healthy male subjects
A Bapat, M Rao, S Vittal, T Mangapathiraju, S Hasham, S Sai, S Alikunju, ...
Diabetes 59, A194-A195, 2010
12010
Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
G Gampa, P Spinosa, J Getz, Y Zhong, W Halpern, E Esen, J Davies, ...
British Journal of Pharmacology, 2024
2024
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20